Skip to main content
CONTEC MEDICAL SYSTEMS CO., LTD. logo

CONTEC MEDICAL SYSTEMS CO., LTD. — Investor Relations & Filings

Ticker · 300869 ISIN · CNE1000047F0 LEI · 6556007SL3V6YKCWVA55 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 789 across all filing types
Latest filing 2023-02-07 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300869

About CONTEC MEDICAL SYSTEMS CO., LTD.

https://www.contecmed.com.cn

CONTEC Medical Systems Co., Ltd. focuses on the research, development, manufacturing, and distribution of medical electronic instruments. The product portfolio encompasses a wide range of diagnostic and monitoring solutions, including pulse oximeters, blood pressure monitors, electrocardiographs, ultrasound equipment, and multi-parameter patient monitors. Additionally, the company provides specialized devices such as fetal monitors, sleep apnea screening systems, and biochemical analyzers. By leveraging integrated research and large-scale production facilities, the organization delivers medical technology designed for clinical, hospital, and home healthcare environments. The company emphasizes technical innovation and adheres to international quality standards to ensure the precision and reliability of its medical hardware and software solutions.

Recent filings

Filing Released Lang Actions
独立董事关于第三届董事会第二十五次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on matters discussed at the 25th meeting of the third board of directors of 康泰医学系统（秦皇岛）股份有限公司. It specifically addresses the approval of the completion of certain fundraising projects and the permanent allocation of surplus funds to working capital. The document references compliance with stock exchange listing rules and company bylaws. It is a formal opinion related to board decisions rather than a full financial report, earnings release, or regulatory filing. It does not contain financial statements or detailed financial data but is related to board/management decisions and approvals. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on board matters, not a report publication or regulatory filing.
2023-02-07 Chinese
第三届董事会第二十五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 25th meeting of the third board of directors of 康泰医学系统（秦皇岛）股份有限公司. It details the meeting date, attendance, agenda items, voting results, and mentions that the board approved a proposal regarding the completion of a fundraising project and the permanent allocation of surplus funds to working capital. It also states that the proposal will be submitted to the shareholders' meeting for approval and that a separate notice for the shareholders' meeting will be issued. The document includes references to independent opinions and verification by the sponsoring institution. The content focuses on board meeting decisions and governance matters rather than financial results, audit reports, or shareholder voting results. It is not a full annual or interim report, nor is it a voting result announcement or a proxy solicitation. Therefore, the document fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors or senior management.
2023-02-07 Chinese
关于首次公开发行股票部分募投项目结项并将节余募集资金永久性补充流动资金的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from 康泰医学系统（秦皇岛）股份有限公司 regarding the completion of a portion of their initial public offering (IPO) investment projects and the permanent allocation of surplus raised funds to supplement working capital. It details the use and management of the IPO proceeds, the approval by the board and supervisory committee, and the need for shareholder approval. The document is a formal disclosure about the use of funds raised from the IPO, including regulatory references to Shenzhen Stock Exchange rules and approvals. It is not a full financial report, earnings release, or management discussion, but rather a regulatory announcement about capital use and project completion. This fits best under Capital/Financing Update (CAP) as it concerns the use and reallocation of capital raised through financing activities. The document length and detail confirm it is not a brief announcement or a report publication notice, but a substantive update on capital usage.
2023-02-07 Chinese
中信建投证券股份有限公司关于康泰医学系统（秦皇岛）股份有限公司首次公开发行股票部分募投项目结项并将节余募集资金永久性补充流动资金的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from a sponsoring securities company regarding the completion and use of funds raised from a company's initial public offering (IPO) of shares. It includes specifics about the fundraising amount, investment projects, changes in project implementation, fund management, and the decision to permanently supplement working capital with surplus funds. The document references regulatory rules and approvals, board and shareholder meetings, and includes an auditor's verification report. It is not a full annual or interim financial report, nor is it a brief announcement or a certification letter. It is a formal audit and verification report related to the use of IPO proceeds and compliance with regulatory requirements, which fits the definition of an Audit Report / Information (AR). The document length is 4043 characters, which is substantial and contains detailed financial and regulatory information, not just an announcement or summary. Therefore, the appropriate classification is AR with high confidence. Q1 2023
2023-02-07 Chinese
关于可转债持有比例变动达10%的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding the change in the holding ratio of convertible bonds by a major shareholder (the controlling shareholder and actual controller). It details the transfer of convertible bonds and the updated holding percentages. There is no financial report, earnings data, or management discussion. The document is a notification about a significant change in bond holdings, which fits the category of a Major Shareholding Notification (MRQ). The document length is short and focused on shareholding changes, not a full report or announcement of a report publication.
2023-01-31 Chinese
关于可转债持有比例变动达10%的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the change in holding proportions of convertible bonds by a major shareholder (the controlling shareholder and actual controller). It details the transfer of convertible bonds and the resulting ownership percentages. There is no financial report, earnings data, or management discussion. The content fits the category of a Major Shareholding Notification, as it reports a significant change in share ownership levels crossing a threshold (10% change in convertible bond holdings).
2023-01-16 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.